Prolia is a monoclonal antibody that binds to a specific protein on osteoclasts and decreases their activity. Osteoclasts are responsible for dissolving and breaking down old or damaged bone cells. By ...
Hosted on MSN
Some Australian patients say they're not being adequately warned about side effects of osteoporosis drug Prolia
Tiffany May, 59, was hiking alone in the Adelaide Hills last year when she fell and lost consciousness. When she came to, she was in intense pain and suspected she'd broken her hip. Hospital scans ...
A similar adverse event (AE) profile was observed in the EVENITY groups, regardless of prior treatment group (placebo or denosumab). In patients treated with EVENITY for months 36 to 48, serious AEs ...
Denosumab (Prolia) is a leading treatment for osteoporosis, but the rapid bone loss that can occur after discontinuing the RANK ligand inhibitor can be challenging to navigate. "I don't think we have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback